The Protective Effects of Resveratrol and l-NAME on Visceral Organs following Aortic Clamping

Annals of Vascular Surgery

Volumn 23, Issue 5, 2009, Pages 675-685

  Budak, B ^a   Seren, M ^a   Turan, N N ^b   Sakaogullari, Z ^a   Ulus, A T ^a  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

N(G) NITROARGININE METHYL ESTER; RESVERATROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA CLAMPING; ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; RABBIT; RENAL PROTECTION; REPERFUSION INJURY; VISCERA;

ANIMALS; AORTA; BIOLOGICAL MARKERS; CONSTRICTION; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; INTESTINES; KIDNEY; LIVER; LUNG; MYOCARDIAL REPERFUSION INJURY; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RABBITS; REPERFUSION INJURY; STILBENES; VISCERA;

EID: 69749120690     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.avsg.2009.04.003     Document Type: Article

References (48)

1. Harward T.R., Welborn III M.B., Martin T.D., et al. Visceral ischemia and organ dysfunction after thoracoabdominal aortic aneurysm repair. A clinical and cost analysis. Ann Surg 223 (1996) 729-736
2. Colletti L.M., Remick D.G., Burtch G.D., Kunkel S.L., Strieter R.M., and Campbell Jr. D.A. Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest 85 (1990) 1936-1943
3. Welbourn R., Goldman G., O'Riordain M., et al. Role for tumor necrosis factor as mediator of lung injury following lower torso ischemia. J Appl Physiol 70 (1991) 2645-2649
4. Kaplan S., Bisleri G., Morgan J.A., Cheema F.H., and Oz M.C. Resveratrol, a natural red wine polyphenol, reduces ischemia-reperfusion-induced spinal cord injury. Ann Thorac Surg 80 (2005) 2242-2249
5. Kobara M., Tatsumi T., Takeda M., et al. The dual effects of nitric oxide synthase inhibitors on ischemia reperfusion injury in rat hearts. Basic Res Cardiol 98 (2003) 319-328
6. Orallo F., Alvarez E., Camina M., Leiro J.M., Gomez E., and Fernandez P. The possible implication of trans-resveratrol in the cardioprotective effects of long-term moderate wine consumption. Mol Pharmacol 61 (2002) 294-302
7. Kiziltepe U., Turan N.N., Han U., Ulus A.T., and Akar F. Resveratrol, a red wine polyphenol, protects spinal cord from ischemia-reperfusion injury. J Vasc Surg 40 (2004) 138-145
8. Hung L.M., Su M.J., Chu W.K., Chiao C.W., Chan W.F., and Chen J.K. The protective effect of resveratrols on ischemia-reperfusion injuries of rat hearts is correlated with antioxidant efficacy. Br J Pharmacol 135 (2002) 1627-1633
9. Shigematsu S., Ishida S., Hara M., et al. Resveratrol, a red wine constituent polyphenol, prevents superoxide-dependent inflammatory responses induced by ischemia/reperfusion, platelet-activating factor, or oxidants. Free Radic Biol Med 34 (2003) 810-817
10. Rotondo S., Rajtar G., Manarini S., et al. Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function. Br J Pharmacol 123 (1998) 1691-1699
11. Fremont L. Biological effects of resveratrol. Life Sci. 66 (2000) 663-673
12. Naderali E.K., Doyle P.J., and Williams G. Resveratrol induces vasorelaxation of mesenteric and uterine arteries from female guinea-pigs. Clin Sci (Lond) 98 (2000) 537-543
13. Ulus A.T., Turan N.N., Seren M., et al. In which period of injury is resveratrol treatment effective: ischemia or reperfusion?. Ann Vasc Surg 21 (2007) 360-366
14. 4 usage on spinal cord ischemia-reperfusion injury: electron microscopic and functional evaluation. Eur Surg Res. 36 (2004) 20-25
15. Elbers P.W., de Haan P., Vanicky I., Legemate D., and Dzoljic M. Effect of temporary visceral ischemia on spinal cord ischemic damage in the rabbit. Ann Thorac Surg 81 (2006) 910-917
16. Katircioglu S.F., Ulus A.T., Gokce P., and Surucu S. Iloprost protects the spinal cord during aortic cross-clamping in a canine model. J Cardiovasc Surg (Torino) 41 (2000) 89-93
17. 2 utilization for spinal cord protection during experimental thoracic aortic occlusion. J Cardiovasc Surg (Torino) 40 (1999) 495-499
18. Beuk R.J., Heineman E., Tangelder G.J., Kurvers H.A., Bonke H.J., and Oude Egbrink M.G. Effects of different durations of total warm ischemia of the gut on rat mesenteric microcirculation. J Surg Res. 73 (1997) 14-23
19. Quaedackers J.S., Beuk R.J., Bennet L., et al. An evaluation of methods for grading histologic injury following ischemia/reperfusion of the small bowel. Transplant Proc. 32 (2000) 1307-1310
20. Stokes K.Y., and Granger D.N. Role of nitric oxide in ischemia-reperfusion i{dotless}njury. In: Ignarro L.J. (Ed). Nitric Oxide Biology and Pathobiology (2000), Academic Press, London 633-647
21. Andriambeloson E., Kleschyov A.L., Muller B., Beretz A., Stoclet J.C., and Andriantsitohaina R. Nitric oxide production and endothelium-dependent vasorelaxation induced by wine polyphenols in rat aorta. Br J Pharmacol 120 (1997) 1053-1058
22. Moncada S., and Higgs A. The l-arginine-nitric oxide pathway. N Engl J Med 329 (1993) 2002-2012
23. Ferdinandy P., Danialn H., Ambrus I., Rothery R.A., and Schultz R. Peroxynitrate is a major contributor to cytokine induced myocardial contractile failure. Circ Res. 87 (2000) 241-247
24. Harward T.R., Welborn III M.B., Martin T.D., et al. Visceral ischemia and organ dysfunction after thoracoabdominal aortic aneurysm repair. A clinical and cost analysis. Ann Surg 223 (1996) 729-736
25. Cambria R.P., Clouse W.D., Davison J.K., Dunn P.F., Corey M., and Dorer D. Thoracoabdominal aneurysm repair: results with 337 operations performed over a 15-year interval. Ann Surg 236 (2002) 471-479
26. Wu J.M., Wang Z.R., Hsieh T.C., Bruder J.L., Zou J.G., and Huang Y.Z. Mechanism of cardioprotection by resveratrol, a phenolic antioxidant present in red wine. Int J Mol Med 8 (2001) 3-17
27. Bradamante S., Barenghi L., and Villa A. Cardiovascular protective effects of resveratrol. Cardiovasc Drug Rev. 22 (2004) 169-188
28. Ng C.S., Wan S., and Yim A.P. Pulmonary ischaemia-reperfusion injury: role of apoptosis. Eur Respir J 25 (2005) 356-363
29. Svensson L.G., Hess K.R., Coselli J.S., Safi H.J., and Crawford E.S. A prospective study of respiratory failure after high-risk surgery on the thoracoabdominal aorta. J Vasc Surg 14 (1991) 271-282
30. Rectenwald J.E., Huber T.S., Martin T.D., et al. Functional outcome after thoracoabdominal aortic aneurysm repair. J Vasc Surg 35 (2002) 640-647
31. Adembri C., Kastamoniti E., Bertolozzi I., et al. Pulmonary injury follows systemic inflammatory reaction in infrarenal aortic surgery. Crit Care Med 32 (2004) 1233-1234
32. Rosenblum J.D., Boyle C.M., and Schwartz L.B. The mesenteric circulation. Anatomy and physiology. Surg Clin North Am. 77 (1997) 289-306
33. Roumen R.M., van der Vliet J.A., Wevers R.A., and Goris R.J. Intestinal permeability is increased after major vascular surgery. J Vasc Surg 17 (1993) 734-737
34. Cuzzocrea S., Chatterjee P.K., Mazzon E., et al. Role of induced nitric oxide in the initiation of the inflammatory response after postischemic injury. Shock 18 (2002) 169-176
35. Montalto M.C., Hart M.L., Jordan J.E., Wada K., and Stahl G.L. Role for complement in mediating intestinal nitric oxide synthase-2 and superoxide dismutase expression. Am J Physiol Gastrointest Liver Physiol 285 (2003) G197-G206
36. Naito Y., Takagi T., Uchiyama K., et al. Suppression of intestinal ischemia-reperfusion injury by a specific peroxisome proliferator-activated receptor-gamma ligand, pioglitazone, in rats. Redox Rep 7 (2002) 294-299
37. Granger D.N. Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 255 (1988) H1269-H1275
38. Grace P.A. Ischaemia-reperfusion injury. Br J Surg 81 (1994) 637-647
39. Achouh P.E., Madsen K., Miller III C.C., et al. Gastrointestinal complications after descending thoracic and thoracoabdominal aortic repairs: a 14-year experience. J Vasc Surg 44 (2006) 442-446
40. Cerqueira N.F., Hussni C.A., and Yoshida W.B. Pathophysiology of mesenteric ischemia/reperfusion: a review. Acta Cir Bras 20 (2005) 336-343
41. Adam D.J., Milne A.A., Evans S.M., et al. Serum amylase isoenzymes in patients undergoing operation for ruptured and non-ruptured abdominal aortic aneurysm. J Vasc Surg 30 (1999) 229-235
42. Fondevila C., Busuttil R.W., and Kupiec-Weglinski J.W. Hepatic ischemia/reperfusion injury-a fresh look. Exp Mol Pathol 74 (2003) 86-93
43. Ikeda T., Yanaga K., Kishikawa K., Kakizoe S., Shimada M., and Sugimachi K. Ischemic injury in liver transplantation: difference in injury sites between warm and cold ischemia in rats. Hepatology 16 (1992) 454-461
44. Martin L.F., Atnip R.G., Holmes P.A., Lynch J.C., and Thiele B.L. Prediction of postoperative complications after elective aortic surgery using stepwise logistic regression analysis. Am Surg 60 (1994) 163-168
45. Jacobs M.J., van Eps R.G., de Jong D.S., Schurink G.W., and Mochtar B. Prevention of renal failure in patients undergoing thoracoabdominal aortic aneurysm repair. J Vasc Surg 40 (2004) 1067-1073
46. Svensson L.G., Crawford E.S., Hess K.R., Coselli J.S., and Safi H.J. Thoracoabdominal aortic aneurysms associated with celiac, superior mesenteric, and renal artery occlusive disease: methods and analysis of results in 271 patients. J Vasc Surg 16 (1992) 378-390
47. Poulias G.E., Doundoulakis N., Skoutas B., et al. Juxtarenal abdominal aneurysmectomy. J Cardiovasc Surg (Torino) 33 (1992) 324-330
48. Lauriat S., and Linas S.L. The role of neutrophils in acute renal failure. Semin Nephrol 18 (1998) 498-504